Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
US11091763B2 · kind B2 · utility
1Cited by
11References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 16, 2019 |
| Grant date | Aug 17, 2021 |
| Priority date | — |
| Expiry date | Dec 16, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions for treating inflammatory disorders of the lower airways are disclosed herein. In one aspect, a method for treating an inflammatory disorder of lower airways in a human subject in need thereof is disclosed, including administering directly to the lower airways in the human subject an effective amount of anakinra, where the effective amount of anakinra is 0.01 mg to 100 mg per day.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.